90-minute Program
Effective
dates for CE credit: 8/31/2021
– 8/31/2023
Description
Automated insulin devices (AID) are becoming more prevalent in the treatment of adults and children with diabetes who require insulin. There are some common challenges in the use of this technology that could lead to significant psychosocial impacts if not mitigated. This webinar will use a case study approach and review published research on the psychosocial considerations for users of this technology.
Learning Outcome
Learners will be able to outline how to match a particular AID system to a person with diabetes based on practical and psychosocial aspects and be able to help mitigate any challenges to use of this technology.
Learning Objectives
At the end of this presentation,
participants will be able to:
-- Describe the current automated insulin devices on the market today.
-- Summarize the automated insulin delivery (AID) clinical trials published for pediatrics and adults with type 1 and type 2 diabetes.
-- Identify common concerns and issues people with diabetes may face using diabetes devices.
-- Review suggested plans of action to help the PWD navigate choosing an AID.
Activity Type
This recording of a live presentation
is a knowledge-based
learning activity.
Learning
Format
Enduring
Material
Intended Audience
ADCES Webinars are designed for
individual or groups of diabetes care and education specialists, including nurses,
dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners,
clinical nurse specialists, physicians, PAs, and other health care providers
interested in staying up to date on current practices of care for people with
diabetes and other related conditions.
Support
This activity is supported by an educational grant from Insulet Corporation.
Cari Berget, RN, MPH, CDCES
Instructor, CU School of Medicine
Manager, Pediatric Artificial Pancreas Research
Aurora, CO
Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES
Program Coordinator, Teen InTransit Program
Kovler Diabetes Center, University of Chicago
Chicago, IL
 |
In
support of improving patient care, the Association of Diabetes Care & Education
Specialists is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC) to provide
continuing education for the healthcare team.
|
|
Accreditation
Council for Pharmacy Education (ACPE)
The
Universal Activity Number is JA4008258-0000-21-525-H01-P.
This knowledge-based
activity has been approved for 1.5 contact hour(s).
This statement contains information provided to NABP from
the Accreditation Council for Pharmacy Education (ACPE) via CPE
Monitor®. ACPE policy states paper and/or
electronic statements of credit may no longer be distributed directly to
learners as proof of ACPE credit. The official record of credit may be located
in the learner’s e-profile in CPE Monitor.
|
|
American
Medical Association (AMA)
Association
of Diabetes Care & Education Specialists designates this enduring
material for a maximum of 1.5
AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
|
|
American
Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this
activity for a maximum of 1.5
ANCC contact hour(s). This activity discusses 0.0 contact hour(s) of pharmacotherapeutic
content.
The
Association of Diabetes Care & Education Specialists is approved by the
California Board of Registered Nursing, Provider Number 10977, for 1.5 contact
hour(s).
|
 |
American
Academy of PAs (AAPA)
The
Association of Diabetes Care & Education Specialists has been
authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME
credit for activities planned in accordance with AAPA CME Criteria. This
activity is designated for 1.5
AAPA Category 1 CME credit(s). Approval is valid until 8/31/23. PAs should only claim credit
commensurate with the extent of their participation.
|
 |
Commission
on Dietetic Registration (CDR)
CDR
Credentialed Practitioners will receive 1.5 Continuing Professional Education unit(s) (CPEU)
for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE
activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related
but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate
with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs
are to select activity type 102 in their Activity Log. Performance Indicator
selection is at the learner’s discretion.
|
Certified Diabetes Care and Education
Specialists
To satisfy the requirements for renewal
of certification for the Certification Board for Diabetes Care and Education
(CBDCE), continuing education activities must be diabetes related and approved
by a provider on the CBDCE list of Approved Providers (www.cbdce.org).
CBDCE does not approve continuing education. The Association of Diabetes Care
& Education Specialists is on the CBDCE list of Approved
Providers.
Board Certified Advanced Diabetes
Management (BC-ADM)
ADCES is the administering body for the
Advanced Diabetes Management credentials. Continuing education programs offered
by ADCES can be used toward fulfilling BC-ADM Certification and recertification
requirements.
Other Health Professionals
It is the responsibility of each
participant to determine if the program meets the criteria for re-licensure or
recertification for their discipline.
Faculty Disclosures
In
accordance with the ACCME Standards for Integrity and Independence, the
Association of Diabetes Care & Education Specialists (ADCES) requires
anyone in a position to affect or control continuing education content (e.g., authors,
presenters, and program planners) to disclose all financial relationships with
ineligible companies. It is the responsibility of ADCES to mitigate and
disclose all relevant conflicts of interest. Disclosure of a relationship is
not intended to suggest or condone bias in any presentation but is made to
provide participants with information that might be of potential importance to
their evaluation of the presentation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Speakers
Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES – Speakers Bureau - Abbott Diabetes Care, Xeris Pharmaceuticals
Cari Berget, RN, MPH, CDCES - Speaker/Consultant - Insulet
Planner
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM – No conflicts of interest
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure and
Mitigation of Relevant Conflicts of Interest
All identified
relevant conflicts of interest have been mitigated.
Joint
Providership
None
Access Period
You
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes
first).
Originally presented
on: 8/31/2021
Expiration
date: 8/31/2023
Pricing
Members:
Free
Non-Members:
$34.95
Volume
discounts are available and will be automatically applied at check-out when the
desired quantity is selected
--
Groups of 4-9: 10% off
--
Groups of 10-19: 20% off
--
Groups of 20-29: 30% off
--
Groups of 30+: Contact education@adces.org
to get a custom quote.
ADCES
CBs and LNGs: Please contact us at education@adces.org
to order a recorded webinar for a group viewing.